Shares of Arena Pharmaceuticals rose 2.46% to $66.27 at 12:06 EST on Tuesday, after two consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 1.01% to $12,000.20, following yesterday’s upward trend, on what up to now seems, an all-around positive trend exchanging session today.
Arena Pharmaceuticals’s last close was $64.68, under its 52-week high of $90.19.
Arena Pharmaceuticals’s sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company’s growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals’s stock is valued at $66.27 at 12:06 EST, way under its 52-week high of $90.19 and way higher than its 52-week low of $32.95.
Arena Pharmaceuticals’s worth is way below its 50-day moving average of $77.88 and below its 200-day moving average of $67.85.